The fat content of milk from dairy cattle infected with bovine leukosis virus

Two groups of cows infected with the bovine leukosis virus (BLV) were kept on two different diets and the fat content of their milk was assayed. The results were compared with those obtained from two comparable groups of BLV-free cows. The cows in each group were of similar ages, those in the groups on the poorer diet being 1–4 months post partum, while those on the richer diet were 5–7 months post partum. The mean percentage of fat in the milk from uninfected cows on the poorer diet was 2.94 while that from the similar infected cattle was 3.06. Uninfected cows on the richer diet produced milk containing 3.39% fat, while those that were infected produced milk containing 3.30% fat. No statistical differences in milk fat production were observed between the BLV seropositive and seronegative cows.     

IMC10200株ALV-J实验诱发禽骨髓性白血病的研究

对分离自肉种鸡群亚临床感染的J亚群禽白血病病毒IMC1o200株进行了实验感染诱发禽骨髓性白血病的病理学研究.IMC10200株J亚群禽白血病病毒尿囊腔接种11日龄肉鸡胚和SPF蛋鸡胚,孵出后跟踪观察.9周龄时随机抽检感染鸡,感染肉鸡特异引物PCR检测全部为阳性;组织病理学观察感染鸡无明显病变.至21周龄时感染肉鸡出现第一例典型骨髓性白血病病例;感染SPF蛋鸡未见明显J亚群禽白血病相关病变.     

Experimental studies with foot-and-mouth disease virus type Asia-1, responsible for the 2005 epidemic in China

This study was carried out to investigate the biological characteristics of the foot-and-mouth disease (FMD) virus strain Asia-1 China/2005, which is responsible for the 2005 epidemic in China. The result showed that this strain is not host restricted, and could not only cause FMD in cattle and sheep but also in pigs by either inoculation or direct contact.     

伪狂犬病毒GDSH株的分离鉴定及gE基因的序列分析

从广东四会某猪场分离到一株疑为猪伪狂犬病病毒(PRV)的病毒,病毒在猪肾细胞上出现细胞变圆、拉网、融合等典型病变,并具有细胞泛嗜性特点。在MDCK细胞上测得其TCID50值为10-8/0.1mL,能被伪狂犬病病毒标准阳性血清中和。将0.1mL病毒液接种小鼠后发生奇痒并麻痹致死,接种猪3天后发病,7天死亡,从攻毒病死猪的脑组织病理切片上观察到典型的病毒性脑膜脑炎及血管套现象。通过PCR扩增到PRVgD基因,由此进一步证明所分离病毒为猪伪狂犬病毒,并命名为GDSH株。根据GenBank中发表的序列,设计一对扩增PRVgE基因的特异性引物,建立可以区分PRV野毒株与疫苗株的PCR诊断方法。以此方法对病毒的细胞培养液进行检测,结果证实所分毒株为PRV野毒株,经克隆测序后与GenBank收录的其它PRVgE基因序列进行比较,发现所测毒株的核苷酸序列与其它PRV毒株的同源性介于98.3%～99.9%之间,其中与PRVEa株的亲缘关系最近为99.9%。     

Effect of rifaximin on gut-lung axis in mice infected with influenza A virus

Gut-lung axis injury is a common finding in patients with respiratory diseases as well as in animal model of influenza virus infection. Influenza virus damages the intestinal microecology while affecting the lungs. Rifaximin, a non-absorbable derivative of rifamycin, is an effective antibiotic that acts by inhibiting bacterial RNA synthesis. This study aimed to determine whether rifaximin-perturbation of the intestinal microbiome leads to protective effects against influenza infection, via the gut-lung axis. Our results showed that influenza virus infection caused inflammation of and damage to the lungs. The expression of tight junction proteins in the lung and colon of H1N1 infected mice decreased significantly, attesting that the barrier structure of the lung and colon was damaged. Due to this perturbation in the gut-lung axis, the intestinal microbiota became imbalanced as Escherichia coli bacteria replicated opportunistically, causing intestinal injury. When influenza infection was treated with rifamixin, qPCR results from the gut showed significant increases in Lactobacillus and Bifidobacterium populations, while Escherichia coli populations markedly decreased. Furthermore, pathology sections and western blotting results illustrated that rifaximin treatment strengthened the physical barriers of the lung-gut axis through increased expression of tight junction protein in the colon and lungs. These results indicated that rifaximin ameliorated lung and intestine injury induced by influenza virus infection. The mechanisms identified were the regulation of gut flora balance and intestinal and lung permeability, which might be related to the regulation of the gut-lung axis. Rifaximin might be useful as a co-treatment drug for the prevention of influenza virus infection.     

病毒细胞受体研究技术及其应用现状

病毒感染宿主细胞的过程实质是病毒受体与配体之间的相互作用。病毒受体和配体的研究是明确病毒致病机理的关键,因此关于病毒细胞受体的研究一直是近年来病毒学研究的重点领域。病毒受体的鉴定可通过多种生物技术手段进行,如酵母双杂交法、病毒覆盖蛋白结合技术等。文章对当前的病毒细胞受体研究技术及其应用现状进行了综述,以期为今后的相关研究提供参考。     

甘草多糖和甘草酸对NDV感染鸡胚成纤维细胞能力的影响

从甘草中提取甘草多糖和甘草酸,进行抗病毒活性比较。用MTT法比较了它们对鸡胚成纤维细胞(CEF)生长及以三种加药方式(先药后毒、先毒后药、药毒同时)抵抗新城疫病毒(NDV)感染细胞的影响,并用平均病毒抑制率比较甘草多糖和甘草酸的抗病毒活性。结果表明,先药后毒,甘草多糖能显著抑制NDV感染细胞(P0.05),平均病毒抑制率为60.6%;先毒后药,甘草多糖和甘草酸都能显著抑制NDV感染细胞(P0.05),其中甘草多糖的平均病毒抑制率为74.28%,甘草酸为62.3%。通过平均病毒抑制率比较,表明甘草多糖的抗病毒活性优于甘草酸。     

牛传染性鼻气管炎病毒LN01/08株灭活疫苗的研制

为研制牛传染性鼻气管炎病毒(IBRV)灭活疫苗,本研究以国内分离鉴定的IBRV LN01/08株为种毒,优化病毒增殖条件,获得病毒滴度达108.0TCID50/mL,将其灭活制备疫苗.为比较不同免疫佐剂的效果,分别以矿物质白油和Montanide ISA206佐剂配制灭活疫苗,进行牛体免疫试验.临床观察和血清中和抗体检测结果表明,Montanide ISA206佐剂乳化的疫苗在降低副反应和增强免疫效果方面优于矿物质白油佐剂.应用Montanide ISA206佐剂制备3批灭活疫苗,并对其安全性和免疫保护效果进行测定.结果表明该疫苗安全可靠,对强毒攻击可产生较好的抵抗力,攻毒保护率达80%.疫苗在2℃～8℃保存12个月后仍能保持良好的免疫效果.     

2008年江苏地区基因Ⅶd亚型新城疫病毒遗传变异分析

为了研究基因Ⅶ d亚型新城疫病毒(Newcastle disease virus,NDV)的分子流行病学及遗传变异规律,作者对2008年分离自江苏地区16株具有一定代表性NDV分离株的F和HN基因片段进行了扩增.根据F基因和HN基因序列绘制的2个遗传进化树基本一致,表明分离株中不存在囊膜糖蛋白基因发生重组的NDV;同时,HN蛋白线性表位发生E347K突变的变异株的分离率在我国呈上升趋势.基因Ⅶd亚型变异株的出现应引起相关领域从业者们的高度重视.     

流感病毒血凝素受体分子的研究进展

血凝素是流感病毒的重要糖蛋白,它的受体研究是目前国际上的热点。作者针对流感病毒的HA受体分子从分子学基础、种属特异性和致病性方面作一综述。